|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 487/04 | |
| A61K 31/519 |
| (11) | Number of the document | 3240791 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15832772.6 |
| Date of filing the European patent application | 2015-12-29 | |
| (97) | Date of publication of the European application | 2017-11-08 |
| (45) | Date of publication and mention of the grant of the patent | 2019-11-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/067831 |
| Date | 2015-12-29 |
| (87) | Number | WO 2016/109515 |
| Date | 2016-07-07 |
| (30) | Number | Date | Country code |
| 201462098141 P | 2014-12-30 | US |
| (72) |
IOANNIDIS, Stephanos, US
TALBOT, Adam Charles, US
FOLLOWS, Bruce, US
BUCKMELTER, Alexandre Joseph, US
WANG, Minghua, US
CAMPBELL, Ann-Marie, US
SCHMIDT, Darby Rye, US
GUERIN, David Joseph, US
CARAVELLA, Justin A., US
DIEBOLD, R. Bruce, US
ERICSSON, Anna, US
LANCIA, David R., Jr., US
|
| (73) |
Forma Therapeutics, Inc.,
500 Arsenal St., Suite 100, Watertown, MA 02472,
US
|
| (54) | PYRROLO AND PYRAZOLOPYRIMIDINES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS |
| PYRROLO AND PYRAZOLOPYRIMIDINES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS |